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Adrenocortical carcinoma (ACC) is a rare 
solid tumor with an incidence of 0.5 to 2 cases 
per million per year. It affects women more 
commonly than men with a ratio of 1.5:1. 
Ectopic ACC are considered to be extremely rare 
with no exact incidence data yet.1-6 We report 
an interesting case of hepatic ACC in a young 
woman with clinical signs of virilization.
A-21-year old Sundanese woman visited 
our endocrine clinic with progressive hirsutism 
over the face, body, and extremities starting 
14 years previously. She had irregular, heavy 
periods when she was 7 years old. She also 
experienced pubertal development of her 
breasts. However, both menstrual cycle and 
breast development ceased when she was 8 years 
old. She noticed voice deepening and alopecia. 
Physical examination showed male-type alopecia 
and intense hirsutism. Tanner stage was 3 for 
breast tissue and 5 for pubic hair. (Figure 1) 
There was no galactorrhea. Body mass index 
was 21.4 kg/m2. Hormonal evaluation revealed 
increased level of free testosterone (>1500 ng/
dl; NV: 8.4-48.1 ng/dl), dehydroepiandrosterone 
sulfate (>1000 ug/ml; NV: 65.1-369 ug/ml), and 
estradiol (533.60 pg/ml; NV: 14-124 pg/ml), low 
level of LH (<0.07 mIU/ml; NV: 1.7-11 mIU/ml) 
and FSH (<0.30 mIU/ml; NV: 1.34-9.40 mIU/
ml), slight increased in morning serum cortisol 
(26.61 ug/ml; NV: 4.3-22.4 ug/ml), normal serum 
thyroid stimulating hormone (3.2 mIU/l; NV: 
0.34-4.25 mIU/l) and prolactin (14.70 ng/ml; NV: 
3.30-15.80 ng/ml). Gynecological ultrasound and 
brain MRI examination showed no structural 
abnormality. Abdominal CT scan demonstrated 
contrast enhanced solid inhomogenous mass 
sized 11.6 x 14.2 x 15.6 cm in right liver 
lobe. (Figure 2) Neither suprarenal mass nor 
paraaortic lymphadenopathy was seen in the 
abdominal CT scan. Chromosomal examination 
revealed normal female karyotype (46, XX). 
Further liver biopsy showed morphology and 
immunohistochemistry (positive for CD 56, 
HEP 1, and NSE) consistent with adrenocortical 
carcinoma. (Figure 3) Surgical therapy with 
referral to other institution was offered to the 
patient as first line treatment. Meanwhile, the 
patient got spironolactone 100 mg OD.
Virilizing tumors are rare and few of 
them are androgen-producing adrenal tumors. 
Ectopic adrenal tumors are even rarer. Ectopic 
adrenal tissue can be found close to the adrenal 
glands, or along the path of descent or in 
association with gonad. Moreover, they have 
ever been reported in nervous system, stomach, 
gall bladder, and liver.4,5,7-9 There have been 
several case reports of adrenal rest tumor of 
liver; however, our literature review found no 
report of ectopic ACC of liver.10-12 Cortical 
tissue, embrologically derived from mesoderm, 
seems to be the sole component of the tumor 
which can undergo malignant transformation 
or become hormonally functional. Functioning 
tumors are more frequent in women. Our case 
demonstrated virilization as chief complaint. The 
ectopically located functioning tumors display 
the same clinical picture as tumors located in 
adrenal gland, with Cushing’s syndrome and 
virilization are the most frequent symptoms 
in order of frequency.11-14 The virilization, as 
shown in our case, is due to excessive androgen 
production of dehydroepiandrosterone sulfate 
and testosterone. The distinction of ACC from 
benign adrenocortical tumor is important. Since 
there is no previous report of hepatic ACC and 
surgery is the keystone of curative treatment 
modality for ACC at adrenal gland, we planned 
the patient for surgical resection.1-3,15,16 Adjuvant 
treatment with chemotherapy (mitotane and 
combination of cytotoxic drugs), irradiation 
might be considered in ACC treatment.2,3 To 
control androgen effects, spironolactone was 
administered in our patient. However, there was 
no significant improvement in symptoms.2,17
In conclusion, we present the first reported 
case of hepatic ACC. A thorough history, physical 
examination, and appropriate laboratory, 
imaging examination are critical in evaluating 
virilized female patients. Elevated serum 
concentration of  dehydroepiandrosterone 
sulfate and testosterone might direct clinician 
to functioning adrenal cortical tissue as etiology, 
with further investigation of exact tumor site.
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